Andy Su's full-year revenue of 10.69 billion yuan Special products will become the driving force for future development

Andesu released its 2016 annual results on the evening of March 29The Company achieved operating income of RMB10.69 billion and net cash flow from operating activities of RMB 3.05 billion in 2016, and net profit attributable to shareholders for the full year was RMB1.87 billion, with a net profit margin of 17.4%In a tough competitive environment in 2016, Andesu maintained a gross margin of nearly 47%, continuing past results and higher than the company's previous performance budgetYtm
The better-than-expected results for 2016Ytm, driven by positive external factors, namely low oil prices and a strong dollar macro environment, the company's performance in 2016 was higher than previously set by the companyThe methionine business has grown in tandem with the market, and the new innovative powdered methionine product, Rodime A-Dry Plus, has received positive feedback from customers and has great potential for developmentThe enzyme business achieved its expected growth target, with new products such as organic selisseo, RosperRova Advance, probiotic Alterion and other product lines growing steadilyThe ruminant products business was affected by the global dairy crisis during the year, but the dairy crisis is now over and sales are expected to pick up this yearIn addition, with higher market prices and the continuous optimization of production costs, Andesu's vitamin business achieved a record high level of profitability in 2016In order to better face the increasingly competitive environment, the company decided to continue to increase investment in European plants to add 50,000 tons of capacity to better meet growing customer demandAt the same time, Andesu's strong cost controls and strict plant management ensured that Andesu remained profitable in the face of falling methionine pricesYtm
In addition to developing its main business, methionine, Andesu is also actively enriching its product portfolio, developing specialty products into the second pillar of the business Ytm
　　Based on the steady development of the methionine business and the success of the specialty products business, the success of Andesu in the face of incentive competition to maintain a high level of profitability, the company's 2016 net profit attributable to shareholders of listed companies to reach 22% of the same period last year, significantly higher than the previous budget of 4% level Ytm
　　Continue to consolidate the position of leader in functional products
Ytm relying on strong capital to focus on investment in a growth and profitability of the market, Andesu is actively achieving sustainable development in the future, the expansion of existing capacity and the integration of bottlenecks, while actively studying the feasibility of establishing a new production platform Ytm
　　With its world-leading manufacturing level, Andesu is one of the lowest production costs, the best quality and most reliable companies in liquid methionine, and Andesu has successfully increased its market share from 23% to 27% in the past four years and is currently a leader in the liquid methionine market Ytm
　　Andesu's ongoing research in the methionine-related field continues to invest heavily to ensure that the most cutting-edge technology is available and that it is more likely to drive breakthrough innovation throughout the industry It follows the announced success of its revolutionary new product, Roddime A-Dry Plus, which will be on the market in early 2018 This product is a new powdered methionine product developed based on liquid methionine technology (HMTBA), which allows customers who cannot use liquid methionine due to product or production processtors to enjoy the benefits of liquid methionine Ytm specialty products will be a strong driving force for the future
Ytm Andesu has successfully developed a number of specialty products (Roethlise, Stemin, Meister, Selisseo, Alterion), Andesu will continue to innovate and develop more animal nutrition additiveproduct products that improve the efficiency of animal protein use Ytm
　　Andesu's technical and technical value-added services, such as the Online Laboratory (E-Lab), Precision Nutritional Analysis (PNE) and Liquid Methionine Addition Technology (DIM), provide customers with analytical and formulated online laboratories (E-Lab), can better solve key technical problems for customers, such as improving feed conversion rates, improving animal health, intestinal health and meat quality levels, and even providing natural antibiotic growth agents Ytm
　　Andesu owns seven laboratories in France and China, with annual research and development costs of about 250 million yuan It is the strong investment in research and development that has ensured that Andesu has launched a new product to the market every year for the past four years At the same time, Andesu is very confident that will continue to maintain the pace of new product development continues to market new products The company's latest product, Alterion, is a natural alternative to antibiotic growth agents on poultry farms, which is being launched by Andy Su and Novixin Ytm looking to the future Ytm Andisu said the company will continue to promote product innovation and service innovation by leveraging its financial resources, actively invest in industry, pursue external mergers and acquisitions, and will continue to increase its investment in emerging markets Ytm Andisu announces its 2016 annual results on the evening of March 29 The Company achieved operating income of RMB10.69 billion and net cash flow from operating activities of RMB 3.05 billion in 2016, and net profit attributable to shareholders for the full year was RMB1.87 billion, with a net profit margin of 17.4% In a tough competitive environment in 2016, Andesu maintained a gross margin of nearly 47%, continuing past results and higher than the company's previous performance budget Ytm
　　The better-than-expected results for 2016 Ytm , driven by positive external factors, namely low oil prices and a strong dollar macro environment, the company's performance in 2016 was higher than previously set by the company The methionine business has grown in tandem with the market, and the new innovative powdered methionine product, Rodime A-Dry Plus, has received positive feedback from customers and has great potential for development The enzyme business achieved its expected growth target, with new products such as organic selisseo, RosperRova Advance, probiotic Alterion and other product lines growing steadily The ruminant products business was affected by the global dairy crisis during the year, but the dairy crisis is now over and sales are expected to pick up this year In addition, with higher market prices and the continuous optimization of production costs, Andesu's vitamin business achieved a record high level of profitability in 2016 In order to better face the increasingly competitive environment, the company decided to continue to increase investment in European plants to add 50,000 tons of capacity to better meet growing customer demand At the same time, Andesu's strong cost controls and strict plant management ensured that Andesu remained profitable in the face of falling methionine prices Ytm
　　In addition to developing its main business, methionine, Andesu is also actively enriching its product portfolio, developing specialty products into the second pillar of the business Ytm
　　Based on the steady development of the methionine business and the success of the specialty products business, the success of Andesu in the face of incentive competition to maintain a high level of profitability, the company's 2016 net profit attributable to shareholders of listed companies to reach 22% of the same period last year, significantly higher than the previous budget of 4% level Ytm
　　Continue to consolidate the position of leader in functional products
Ytm relying on strong capital to focus on investment in a growth and profitability of the market, Andesu is actively achieving sustainable development in the future, the expansion of existing capacity and the integration of bottlenecks, while actively studying the feasibility of establishing a new production platform Ytm
　　With its world-leading manufacturing level, Andesu is one of the lowest production costs, the best quality and most reliable companies in liquid methionine, and Andesu has successfully increased its market share from 23% to 27% in the past four years and is currently a leader in the liquid methionine market Ytm
　　Andesu's ongoing research in the methionine-related field continues to invest heavily to ensure that the most cutting-edge technology is available and that it is more likely to drive breakthrough innovation throughout the industry It follows the announced success of its revolutionary new product, Roddime A-Dry Plus, which will be on the market in early 2018 This product is a new powdered methionine product developed based on liquid methionine technology (HMTBA), which allows customers who cannot use liquid methionine due to product or production processtors to enjoy the benefits of liquid methionine Ytm specialty products will be a strong driving force for the future
Ytm Andesu has successfully developed a number of specialty products (Roethlise, Stemin, Meister, Selisseo, Alterion), Andesu will continue to innovate and develop more animal nutrition additiveproduct products that improve the efficiency of animal protein use Ytm
　　Andesu's technical and technical value-added services, such as the Online Laboratory (E-Lab), Precision Nutritional Analysis (PNE) and Liquid Methionine Addition Technology (DIM), provide customers with analytical and formulated online laboratories (E-Lab), can better solve key technical problems for customers, such as improving feed conversion rates, improving animal health, intestinal health and meat quality levels, and even providing natural antibiotic growth agents Ytm
　　Andesu owns seven laboratories in France and China, with annual research and development costs of about 250 million yuan It is the strong investment in research and development that has ensured that Andesu has launched a new product to the market every year for the past four years At the same time, Andesu is very confident that will continue to maintain the pace of new product development continues to market new products The company's latest product, Alterion, is a natural alternative to antibiotic growth agents on poultry farms, which is being launched by Andy Su and Novixin Ytm looking to the future Ytm Andisu said the company will continue to promote product innovation and service innovation by leveraging its financial resources, actively invest in industry, pursue external mergers and acquisitions, and will continue to increase its investment in emerging markets Ytm